These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38169425)

  • 1. Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function.
    Kidani Y; Kitagawa Y; Hagiwara M; Kawashima A; Kanazawa T; Wada H; Uemura M; Nonomura N; Motooka D; Nakamura S; Ohkura N; Sakaguchi S
    Int Immunol; 2024 Mar; 36(4):167-182. PubMed ID: 38169425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.
    Mao CD; Byers SW
    Crit Rev Eukaryot Gene Expr; 2011; 21(3):207-36. PubMed ID: 22111711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD103 is a hallmark of tumor-infiltrating regulatory T cells.
    Anz D; Mueller W; Golic M; Kunz WG; Rapp M; Koelzer VH; Ellermeier J; Ellwart JW; Schnurr M; Bourquin C; Endres S
    Int J Cancer; 2011 Nov; 129(10):2417-26. PubMed ID: 21207371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function.
    Whiteside SK; Grant FM; Gyori DS; Conti AG; Imianowski CJ; Kuo P; Nasrallah R; Sadiyah F; Lira SA; Tacke F; Eil RL; Burton OT; Dooley J; Liston A; Okkenhaug K; Yang J; Roychoudhuri R
    Immunology; 2021 Aug; 163(4):512-520. PubMed ID: 33838058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Treg cells in cancer immunotherapy.
    Tanaka A; Sakaguchi S
    Eur J Immunol; 2019 Aug; 49(8):1140-1146. PubMed ID: 31257581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD1 is transcriptionally regulated by LEF1 in mature T cells.
    Zhao P; Sun L; Zhao C; Malik S
    Immunobiology; 2023 Sep; 228(5):152708. PubMed ID: 37523793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo.
    Willinger T; Freeman T; Herbert M; Hasegawa H; McMichael AJ; Callan MF
    J Immunol; 2006 Feb; 176(3):1439-46. PubMed ID: 16424171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function.
    Zhu F; Yi G; Liu X; Zhu F; Zhao A; Wang A; Zhu R; Chen Z; Zhao B; Fang S; Yu X; Lin R; Liang R; Li D; Zhao W; Zhang Z; Guo W; Zhang S; Ge S; Fan X; Zhao G; Li B
    J Biol Chem; 2018 Dec; 293(52):20099-20111. PubMed ID: 30389786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells.
    Morikawa H; Sakaguchi S
    Immunol Rev; 2014 May; 259(1):192-205. PubMed ID: 24712467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive IL-17A
    Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
    Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation.
    Morikawa H; Ohkura N; Vandenbon A; Itoh M; Nagao-Sato S; Kawaji H; Lassmann T; Carninci P; Hayashizaki Y; Forrest AR; Standley DM; Date H; Sakaguchi S;
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5289-94. PubMed ID: 24706905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
    Sahin E; Sahin M
    J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
    Sugiyama D; Nishikawa H; Maeda Y; Nishioka M; Tanemura A; Katayama I; Ezoe S; Kanakura Y; Sato E; Fukumori Y; Karbach J; Jäger E; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17945-50. PubMed ID: 24127572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression.
    Fragale A; Gabriele L; Stellacci E; Borghi P; Perrotti E; Ilari R; Lanciotti A; Remoli AL; Venditti M; Belardelli F; Battistini A
    J Immunol; 2008 Aug; 181(3):1673-82. PubMed ID: 18641303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification.
    Samstein RM; Arvey A; Josefowicz SZ; Peng X; Reynolds A; Sandstrom R; Neph S; Sabo P; Kim JM; Liao W; Li MO; Leslie C; Stamatoyannopoulos JA; Rudensky AY
    Cell; 2012 Sep; 151(1):153-66. PubMed ID: 23021222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranuclear interactomic inhibition of FoxP3 suppresses functions of Treg cells.
    Park JH; Ko JS; Shin Y; Cho JY; Oh HA; Bothwell AL; Lee SK
    Biochem Biophys Res Commun; 2014 Aug; 451(1):1-7. PubMed ID: 25044110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.